Nuwellis (NUWE) Competitors $6.89 -0.92 (-11.78%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$16.52 +9.63 (+139.78%) As of 07:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUWE vs. INFU, PTHL, AVR, MGRM, LUCD, OBIO, LUNG, ICAD, FONR, and NTRBShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include InfuSystem (INFU), Pheton (PTHL), Anteris Technologies Global (AVR), Monogram Orthopaedics (MGRM), Lucid Diagnostics (LUCD), Orchestra BioMed (OBIO), Pulmonx (LUNG), icad (ICAD), Fonar (FONR), and Nutriband (NTRB). These companies are all part of the "medical equipment" industry. Nuwellis vs. Its Competitors InfuSystem Pheton Anteris Technologies Global Monogram Orthopaedics Lucid Diagnostics Orchestra BioMed Pulmonx icad Fonar Nutriband Nuwellis (NASDAQ:NUWE) and InfuSystem (NYSE:INFU) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership. Do institutionals & insiders hold more shares of NUWE or INFU? 3.1% of Nuwellis shares are owned by institutional investors. Comparatively, 71.1% of InfuSystem shares are owned by institutional investors. 2.6% of Nuwellis shares are owned by company insiders. Comparatively, 11.4% of InfuSystem shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has better valuation & earnings, NUWE or INFU? InfuSystem has higher revenue and earnings than Nuwellis. Nuwellis is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuwellis$8.74M0.08-$11.16M-$766.39-0.01InfuSystem$137.58M0.84$870K$0.1439.14 Does the media favor NUWE or INFU? In the previous week, Nuwellis had 5 more articles in the media than InfuSystem. MarketBeat recorded 6 mentions for Nuwellis and 1 mentions for InfuSystem. Nuwellis' average media sentiment score of 1.24 beat InfuSystem's score of 0.59 indicating that Nuwellis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nuwellis 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InfuSystem 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, NUWE or INFU? Nuwellis has a beta of 0.28, indicating that its stock price is 72% less volatile than the S&P 500. Comparatively, InfuSystem has a beta of 1.81, indicating that its stock price is 81% more volatile than the S&P 500. Do analysts rate NUWE or INFU? Nuwellis currently has a consensus target price of $714.00, indicating a potential upside of 10,262.84%. InfuSystem has a consensus target price of $13.00, indicating a potential upside of 137.23%. Given Nuwellis' higher probable upside, equities analysts plainly believe Nuwellis is more favorable than InfuSystem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nuwellis 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00InfuSystem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 2 Strong Buy rating(s) 4.00 Is NUWE or INFU more profitable? InfuSystem has a net margin of 1.12% compared to Nuwellis' net margin of -112.09%. InfuSystem's return on equity of 2.78% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets Nuwellis-112.09% -655.31% -141.83% InfuSystem 1.12%2.78%1.41% SummaryInfuSystem beats Nuwellis on 13 of the 17 factors compared between the two stocks. Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUWE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUWE vs. The Competition Export to ExcelMetricNuwellisMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$810K$6.76B$5.61B$9.29BDividend YieldN/A1.21%4.23%4.03%P/E Ratio-0.0125.9728.5419.58Price / Sales0.0861.63429.2495.01Price / CashN/A20.3636.0257.93Price / Book0.114.638.145.54Net Income-$11.16M$174.76M$3.24B$257.73M7 Day Performance-6.64%-3.25%0.18%-0.08%1 Month Performance-41.39%-0.33%5.96%8.09%1 Year Performance-96.42%0.36%26.24%13.02% Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUWENuwellis3.2875 of 5 stars$6.89-11.8%$714.00+10,262.8%-96.1%$810K$8.74M-0.0170News CoverageHigh Trading VolumeINFUInfuSystem3.1169 of 5 stars$6.13-1.9%$13.00+112.1%N/A$128.83M$137.58M102.18410PTHLPhetonN/A$19.40-0.8%N/AN/A$127.65M$450K0.0011High Trading VolumeAVRAnteris Technologies GlobalN/A$3.51+0.9%$16.50+370.1%N/A$126.58M$2.49M0.00138Gap UpMGRMMonogram Orthopaedics1.0391 of 5 stars$3.30+13.4%$5.40+63.6%+173.1%$117.77MN/A-7.3328LUCDLucid Diagnostics2.6017 of 5 stars$1.06+1.9%$3.55+234.9%+32.9%$114.68M$4.35M-0.7970News CoveragePositive NewsOBIOOrchestra BioMed2.9251 of 5 stars$2.93+1.4%$14.20+384.6%-65.8%$112.25M$2.64M-1.654LUNGPulmonx3.4511 of 5 stars$2.73+3.4%$11.53+322.2%-65.2%$109.91M$83.79M-1.90250ICADicad0.6913 of 5 stars$3.72+0.3%N/A+198.4%$102.19M$19.53M-19.58140News CoverageGap UpFONRFonar1.2277 of 5 stars$15.59+0.8%N/A-4.8%$96.71M$103.02M12.47480NTRBNutriband3.0496 of 5 stars$8.21-3.1%$13.00+58.3%+18.3%$91.54M$2.14M-9.1210Positive News Related Companies and Tools Related Companies INFU Alternatives PTHL Alternatives AVR Alternatives MGRM Alternatives LUCD Alternatives OBIO Alternatives LUNG Alternatives ICAD Alternatives FONR Alternatives NTRB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NUWE) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NUWE Stock Alerts